BioCision has released three new cryopreservation systems to deliver a controlled freezing rate of -1°C/minute in a -80°C freezer, with high reproducibility of freezing profiles and consistent cell viability and function after thawing.
CoolCell FTS30 uses a patented alloy-based micro-convection heat removal technology to uniformly freeze 30-vial batches in a compact space.
BioCision said it is ideal for all cells including cell lines, stem cells, yeast, blood and other primary cells.
CoolCell SV2 is meant for freezing larger diameter 2ml vials, such as Crystal Zenith 1 vials for freezing dendritic cells and other cells used in basic and clinical research applications.
CoolCell 5ml is for large-volume cryovials.
BioCision CEO Rolf Ehrhardt said they will be releasing additional sample cryopreservation products over the coming months to meet the growing demands of cell research, cell therapy, and the diagnostic market.